Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Am J Surg Pathol. 2012 Feb;36(2):242–252. doi: 10.1097/PAS.0b013e31823d07f3

Table 1.

Tumors tested with sst2A immunohistochemistry and in vitro 125I-[Tyr3]-octreotide autoradiography

Gastrointestinal neuroendocrine tumors*
Pancreas 2 non-functioning neuroendocrine tumors
17 non-functioning well differentiated neuroendocrine carcinomas
11 insulin-producing neuroendocrine tumors
1 insulin-producing well differentiated neuroendocrine carcinoma
1 glucagon-producing well differentiated neuroendocrine carcinoma
1 serotonin-producing neuroendocrine tumor
1 somatostatin-producing well differentiated neuroendocrine carcinoma
Extrahepatic bile duct 1 well differentiated neuroendocrine carcinoma
Gall bladder 1 well differentiated neuroendocrine carcinoma
Liver 1 well differentiated neuroendocrine carcinoma
Stomach 1 well differentiated neuroendocrine carcinoma
Ileum 10 well differentiated neuroendocrine carcinomas
Vermiform appendix 1 well differentiated neuroendocrine carcinoma
Sigmoid colon 1 well differentiated neuroendocrine carcinoma
Extra-gastrointestinal neuroendocrine tumors
Adrenal gland 5 pheochromocytomas
1 ganglioneuroblastoma
Extraadrenal paraganglia 2 retroperitoneal paragangliomas
1 mediastinal ganglioneuroblastoma
Mesentery 1 well differentiated neuroendocrine carcinoma
Lung 10 typical carcinoid tumors
Thymus 1 carcinoid tumor
Non-neuroendocrine tumors 4 meningiomas
14 breast carcinomas
*

Classification of retrospectively analyzed neuroendocrine tumors according to WHO 2004